Original Article
Identification of key mutations in central nervous diffuse large B-cell lymphoma (DLBCL) by comprehensive analysis between sequencing and TCGA database
Translational Cancer Research
2021;
10
(6)
:2632-2642
.
(28 June 2021)
Prognostic significance of pyruvate kinase M2 expression in esophageal squamous cell carcinoma and its meta-analysis
Translational Cancer Research
2021;
10
(6)
:2643-2652
.
(28 June 2021)
Endoscopic resection versus esophagectomy for early esophageal cancer: a meta-analysis
Translational Cancer Research
2021;
10
(6)
:2653-2662
.
(28 June 2021)
Progesterone receptor gene serves as a prognostic biomarker associated with immune infiltration in gastric cancer: a bioinformatics analysis
Translational Cancer Research
2021;
10
(6)
:2663-2677
.
(28 June 2021)
The prognostic value and immunological role of the small mother against decapentaplegic proteins in kidney renal clear cell carcinoma
Translational Cancer Research
2021;
10
(6)
:2678-2693
.
(28 June 2021)
Overexpression of microRNA-19a-3p promotes lymph node metastasis of esophageal squamous cell carcinoma via the RAC1/ CDC42-PAK1 pathway
Translational Cancer Research
2021;
10
(6)
:2694-2706
.
(28 June 2021)
Bioinformatic analysis of PLOD family member expression and prognostic value in non-small cell lung cancer
Translational Cancer Research
2021;
10
(6)
:2707-2724
.
(28 June 2021)
Genome-wide expression changes mediated by A-to-I RNA editing correlate with hepatic oncogenesis
Translational Cancer Research
2021;
10
(6)
:2725-2737
.
(28 June 2021)
Prognostic and diagnostic value of SOX9 in cirrhotic and noncirrhotic hepatocellular carcinoma
Translational Cancer Research
2021;
10
(6)
:2738-2746
.
(28 June 2021)
Second primary oral squamous cell carcinoma after radiotherapy: a retrospective cohort study
Translational Cancer Research
2021;
10
(6)
:2747-2754
.
(28 June 2021)
Invasive adenocarcinoma manifesting as pure ground glass nodule with different size: radiological characteristics differ while prognosis remains the same
Translational Cancer Research
2021;
10
(6)
:2755-2766
.
(28 June 2021)
Effects of a combined treatment regimen consisting of Hsp90 inhibitor DS-2248 and radiation in vitro and in a tumor mouse model
Translational Cancer Research
2021;
10
(6)
:2767-2776
.
(28 June 2021)
The value of enhanced computed tomography combined with magnetic resonance imaging in the differential diagnosis of thymomas and thymic cysts before operation
Translational Cancer Research
2021;
10
(6)
:2777-2789
.
(28 June 2021)
Development of a novel autophagy-related gene prognostic signature for gastric cancer
Translational Cancer Research
2021;
10
(6)
:2790-2800
.
(28 June 2021)
E2F1/2/4 mRNA is associated with immune infiltration and are potential biomarkers for the prognosis of human gastric carcinoma
Translational Cancer Research
2021;
10
(6)
:2801-2811
.
(28 June 2021)
Analyzing microsatellite instability and gene mutation in circulating cell-free DNA to monitor colorectal cancer progression
Translational Cancer Research
2021;
10
(6)
:2812-2821
.
(28 June 2021)
Prediction of axillary response after neoadjuvant chemotherapy in clinical node positive breast cancer
Translational Cancer Research
2021;
10
(6)
:2822-2830
.
(28 June 2021)
Identification of hub genes in gastric cancer by integrated bioinformatics analysis
Translational Cancer Research
2021;
10
(6)
:2831-2840
.
(28 June 2021)
Low-dose spectral CT perfusion imaging of lung cancer quantitative analysis in different pathological subtypes
Translational Cancer Research
2021;
10
(6)
:2841-2848
.
(28 June 2021)
Efficacy and toxicity in scheduled intravesical gemcitabine versus Bacille Calmette-Guérin for Ta and T1 bladder cancer: a systematic review and meta-analysis
Translational Cancer Research
2021;
10
(6)
:2849-2858
.
(28 June 2021)
Systemic immune microenvironment and regulatory network analysis in patients with lung adenocarcinoma
Translational Cancer Research
2021;
10
(6)
:2859-2872
.
(28 June 2021)
Prognostic value of treatment options for extramammary Paget’s disease: a SEER database analysis
Translational Cancer Research
2021;
10
(6)
:2873-2881
.
(28 June 2021)
Systemic characterization of the SLC family genes reveals SLC26A6 as a novel oncogene in hepatocellular carcinoma
Translational Cancer Research
2021;
10
(6)
:2882-2894
.
(28 June 2021)
The correlation between the abundance of EGFR T790M mutation and osimertinib response in advanced non-small cell lung cancer
Translational Cancer Research
2021;
10
(6)
:2895-2905
.
(28 June 2021)
Telomere in colorectal cancer associated with distant metastases and predicted a poor prognosis
Translational Cancer Research
2021;
10
(6)
:2906-2917
.
(28 June 2021)
Effect of selective lymph node dissection on immune function in patients with T1 stage non-small cell lung cancer: a randomized controlled trial
Translational Cancer Research
2021;
10
(6)
:2918-2931
.
(28 June 2021)
Age plays an important role in the decision of definitive concurrent chemoradiotherapy (CCRT) for esophageal squamous cell carcinoma (ESCC): a propensity-score matched analysis of multicenter data (3JECROG R-02A)
Translational Cancer Research
2021;
10
(6)
:2932-2943
.
(28 June 2021)
Effect of LHX2 gene methylation level and its function on radiotherapy of cervical cancer
Translational Cancer Research
2021;
10
(6)
:2944-2961
.
(28 June 2021)
Immune-related gene ANGPT1 is an adverse biomarker for endometrial carcinoma
Translational Cancer Research
2021;
10
(6)
:2962-2976
.
(28 June 2021)
Clinical pathological analysis of newly diagnosed malignant pelvic tumors during pregnancy
Translational Cancer Research
2021;
10
(6)
:2977-2984
.
(28 June 2021)
Effectiveness of ultrasound-guided percutaneous transhepatic puncture for the diagnosis of low-level alpha-fetoprotein liver cancer patients
Translational Cancer Research
2021;
10
(6)
:2985-2990
.
(28 June 2021)
Using immune-related lncRNAs to construct novel biomarkers and investigate the immune landscape of breast cancer
Translational Cancer Research
2021;
10
(6)
:2991-3003
.
(28 June 2021)
Propofol induces apoptosis of hepatocellular carcinoma cells by upregulating miR-134 expression
Translational Cancer Research
2021;
10
(6)
:3004-3012
.
(28 June 2021)
Application of data mining in the provision of in-home medical care for patients with advanced cancer
Translational Cancer Research
2021;
10
(6)
:3013-3019
.
(28 June 2021)
Regulation of dynamin-related protein 1 (DRP1) levels modulates myoblast atrophy induced by C26 colon cancer-conditioned medium
Translational Cancer Research
2021;
10
(6)
:3020-3032
.
(28 June 2021)
Clinicopathological features of pulmonary artery and vein intimal sarcomas: case series of rare pulmonary vessel intimal sarcoma
Translational Cancer Research
2021;
10
(6)
:3033-3043
.
(28 June 2021)
Review Article
Vasculogenic mimicry in head and neck tumors: a narrative review
Translational Cancer Research
2021;
10
(6)
:3044-3052
.
(28 June 2021)
Case Report
A case report of endoscopic submucosal dissection for a new subtype of gastric adenoma: mixed fundic and pyloric mucosa type
Translational Cancer Research
2021;
10
(6)
:3053-3058
.
(28 June 2021)
Anaplastic ganglioglioma originating from the medulla oblongata: case report
Translational Cancer Research
2021;
10
(6)
:3059-3066
.
(28 June 2021)
Primary bladder schwannoma: a case report and literature review
Translational Cancer Research
2021;
10
(6)
:3067-3073
.
(28 June 2021)
Sclerosing encapsulating peritonitis as a rare cause of intestinal obstruction after the treatment of peritoneal mesothelioma: a case report and review of the literature
Translational Cancer Research
2021;
10
(6)
:3074-3080
.
(28 June 2021)
Complex genetic alterations contribute to rapid disease progression in an ALK rearrangement lung adenocarcinoma patient: a case report
Translational Cancer Research
2021;
10
(6)
:3081-3086
.
(28 June 2021)
Editorial on Clinic and Therapeutic Potential of Non-coding RNAs in Cancer1
Clinic and therapeutic potential of non-coding RNAs in cancer
Translational Cancer Research
2021;
10
(6)
:3087-3089
.
(28 June 2021)
Review Article on Clinic and Therapeutic Potential of Non-coding RNAs in Cancer1
MicroRNAs in head and neck squamous cell carcinoma: a possible challenge as biomarkers, determinants for the choice of therapy and targets for personalized molecular therapies
Translational Cancer Research
2021;
10
(6)
:3090-3110
.
(28 June 2021)
Vitamin D modulation and microRNAs in gastric cancer: prognostic and therapeutic role
Translational Cancer Research
2021;
10
(6)
:3111-3127
.
(28 June 2021)
Exosomal microRNAs in non-small cell lung cancer
Translational Cancer Research
2021;
10
(6)
:3128-3139
.
(28 June 2021)
Long non-coding RNAs regulating multiple proliferative pathways in cancer cell
Translational Cancer Research
2021;
10
(6)
:3140-3157
.
(28 June 2021)
Disclosure:
1. The series “Clinic and Therapeutic Potential of Non-coding RNAs in Cancer” was commissioned by the editorial office, Translational Cancer Research without any sponsorship or funding. Alfons Navarro, Joan J. Castellano and Marina Díaz-Beyá served as the unpaid Guest Editors for the series.
